MicroRNA-106b is involved in transforming growth factor β1–induced cell migration by targeting disabled homolog 2 in cervical carcinoma

Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression

(2015) Alexandra Fullár et al.   BMC CANCER

Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta

(2015) Michikazu Nagura et al.   GYNECOLOGIC ONCOLOGY

The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer

(2015) Ryunosuke Kogo et al.   Oncotarget

Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein

(2015) Ram Prasad et al.   Oncotarget

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma

(2014) Bin-Kui Li et al.   Diagnostic Pathology

MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN

(2014) Ting-Song Yang et al.   FEBS LETTERS

BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10

(2014) Chang Gong et al.   Nature Communications

MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells

(2013) C Gong et al.   ONCOGENE

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer

(2013) L Du et al.   ONCOGENE

The miR-106b-25 cluster targets Smad7, activates TGF-β signaling and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer

(2012) A L Smith et al.   ONCOGENE

Worldwide burden of cervical cancer in 2008

(2011) M. Arbyn et al.   ANNALS OF ONCOLOGY

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition

(2010) J C Martin et al.   BRITISH JOURNAL OF CANCER

Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter

(2010) Adèle Hannigan et al.   JOURNAL OF CLINICAL INVESTIGATION

HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition

(2009) Karin Hellner et al.   VIROLOGY

Molecular Diagnosis of Sentinel Lymph Node Metastases in Cervical Cancer Using Squamous Cell Carcinoma Antigen

(2008) S.-H. Yuan et al.   CLINICAL CANCER RESEARCH

MicroRNA-134 Modulates the Differentiation of Mouse Embryonic Stem Cells, Where It Causes Post-Transcriptional Attenuation of Nanog and LRH1

(2007) Yvonne M.-S. Tay et al.   STEM CELLS